Moderna, Inc. Common Stock (MRNA) Sentiment
30-day SentiSense Score 32.07 · Bullish · ▼ cooling · as of 2026-09-23
MRNA sentiment is strong bullish (30-day SentiSense Score 32) and cooling from a month ago; today's read has cooled to 27, below its 30-day average. Attention averages ~44 mentions/day (25 today).
- Sentiment (30-day)
- Strong Bullish
- SentiSense Score (30-day avg)
- 32.07
- Today's read
- 27.23 (Bullish)
- Mentions / day (30-day avg)
- 44 (25 today)
Where the conversation is happening
- News
- Bullish · 62% of mentions
- X
- Bullish · 28% of mentions
- Bullish · 5% of mentions
- YouTube
- Bullish · 3% of mentions
- Substack
- Neutral · 2% of mentions
Related tickers
What's driving it
- Moderna Shares Surge Over 12% on Melanoma Vaccine Data and Upcoming Pipeline Updates (+0.8)
- FDA clears updated Pfizer and Moderna COVID vaccines for the 2026-27 season (+0.82)
- Moderna raises $2 billion in convertible notes for general corporate purposes, not a dedicated cancer-vaccine fund (+0.22)
Live SentiSense Score, sentiment history, and per-source breakdown for Moderna, Inc. Common Stock on SentiSense.
See how MRNA's sector compares in the market sentiment heatmap